Jubilant Pharmova Ltd News

Jubilant Pharmova arm to invest $300 mn in US to double injectable capacity

Jubilant HollisterStier LLC, an arm of Jubilant Pharmova Ltd, will invest USD 300 million by FY28 in the US to double its sterile injectable manufacturing capacity, with President Donald Trump's tariffs accelerating its original plans, company CEO - CDMO Sterile Injectables, Chris Preti, said on Friday. The company has launched its new sterile fill and finish line -- the third at its Spokane manufacturing facility in Washington, US, set up at an investment of USD 132 million, Preti told PTI. "Our overall investment is almost USD 300 million at our Spokane facility. This is the first of the two phases ... This USD 132 million is phase one, which is our third line," he said. Preti further said, "This will bring an additional 50 per cent of capacity in the US that is available now and then, the additional investment, totaling USD 300 million in all, will be actually completed by the end of fiscal year 2028 which will bring on another 50 per cent of additional capacity." On the company